2don MSN
Notable healthcare headlines for the week: Eli Lilly, UnitedHealth, and Boston Scientific in focus
Wall Street on Friday ended a listless day with marginal losses, with the session echoing the overall movement seen this week ...
Eli Lilly is aware of this fact, which helps explain why it acquired Adverum Biotechnologies in late 2025 and just agreed to ...
Eli Lilly (LLY) achieved 54% year-over-year revenue growth to $17.6B in Q3. Tirzepatide is projected as the top-selling drug by 2030. Lilly raised its quarterly dividend 15% to $1.73 per share. The ...
Zacks.com on MSN
The Zacks Analyst Blog Eli Lilly, Medtronic, Intuitive Surgical, Regeneron Pharmaceuticals and Johnson & Johnson
Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.
Healthcare is the only one of the S&P 500's 11 sectors that is showing weakness on the day, with the Health Care Select Sector SPDR ETF down 0.6% in recent trading. Eli Lilly's stock was shedding 2.5% ...
The stock's fall snapped a two-day winning streak.
AI chipmaker Nvidia ( NVDA) and pharmaceutical giant Eli Lilly ( LLY) on Monday announced that the two companies will jointly ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback